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Introduction
            Junctional ectopic tachycardia (JET) is a rare type of supraventricular arrhythmia. Even 
if its management has improved in recent years, it remains a great challenge for the cardiologist. 
Two are the possible clinical presentations of this arrhythmia: as a primary idiopathic disorder 
during infancy, configuring the so called "congenital" JET, or more often as a transient 
phenomenon immediately after surgery for congenital heart disease, giving rise to the "post-
operative" variety. The congenital form, firstly described as a distinct entity by Coumel et al. in 
19761, usually occurs in the first six months of life presenting as a persistent sustained form, 
lasting up to 90% of the time. Its clinical presentation may be dramatic, being associated in up to 
60% of cases with cardiomegaly and/or heart failure. Congenital JET is hampered by high 
mortality. Secondary dilated cardiomyopathy, ventricular fibrillation and sudden cardiac death 
have also been reported  2,3.                                                                                                       
Clinical Presentation                                                                                                           
            Clinical presentation of congenital JET usually ranges from birth to 4 weeks of age. 
Sporadic cases of history of intrauterine tachycardia, with sometimes hydrops fetalis, have been 
reported in patients who at birth showed overt JET 2,4,5. Usually, high percentage of patients 
present, at the time of referring, echocardiographyc evidences of impaired left ventricle function 
and clinical signs of congestive heart failure. However, it has been noted that age of tachycardia 
presentation is not related to the occurrence of congestive heart failure or impaired left 
ventricular function. On the contrary, clinical status seems related to the ventricular rate at 
presentation6. The incidence of congenital heart disease in presence of congenital junctional 
ectopic tachycardia has been reported sporadic6.                                                             
Diagnostic   Assessment                                                                          
            The diagnosis of junctional ectopic tachycardia usually is based on electrocardiographic 
evidence of a narrow complex tachycardia (heart rate ranging from 160 bpm to 300 bpm) and 
atrio-ventricular dissociation. (Figure 1) Sometimes, it is possible to observe slight variation of 
heart rate during the 24 hours and irregularity in the RR due to sinus capture beats. Distinct P 
waves can be seen only in the tracing of the patients with slower heart rate following drug 
treatment.   Prenatal   diagnosis   of   JET   has   been   also   reported,   with   the   superior   vena 
cava/ascending  aorta  Doppler   echocardiography  approach  4.   Doppler   wave   showed   AV 
dissociation with aortic ejection occurring at smaller interval than venous retrograde flow due to 
atrial contractions and "a" waves occurring at a very short interval after aortic ejection, during 
periods of 1:1 AV relationship tachycardia.
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Figure 1: Junctional ectopic tachycardia : a narrow complex tachycardia with atrio-ventricular 
dissociation
Electrophysiological Mechanism                                                                                                 
            Electrophysiological mechanism of JET is thought to be abnormal automaticity within 
the His bundle 7. JET typically presents a "warming-up" phase at its onset and a "cooling-down" 
phase at its termination. It is usually unresponsive to overdrive pacing or DC shock. When there 
is retrograde conduction, adenosine infusion can rule out the diagnosis of AV reciprocating 
tachycardia, because of tachycardia cycle lengthening without termination of the arrhythmia 8. 
            Tachycardia is not inducible by programmed stimulation in baseline status, but can be 
elicited after sympathetic stimulation with isoproterenol. Programmed atrial and ventricular 
stimulation usually are not able to terminate tachycardia, that can be only transiently suppressed 
by atrial and/or ventricular pacing, exhibiting a resetting curve-response to extrastimuli during 
tachycardia. JET can coexist with the occurrence of other types of arrhythmias. Scheinman et 
al.9 reported the development of JET after catheter ablation of persistent junctional reciprocating 
tachycardia in one patient, but a differentiation between a masking   effect   of   the   latter 
tachycardia on JET and a procedure related genesis of JET itself could not be argued.
Familiar   occurrence                                                                              
             Even more interest is attributed to this arrhythmia by the fact that it is a familiar 
condition. In a multicenter study, Villain reports a familiar history of JET positive in 50% of the 
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children2. In our experience up to three members of the same family (2 sisters, 1 cousin) were 
affected by JET with a family history of JET recognised in up to 55.6% of the patients6. These 
characteristics suggest a possible Mendelian inheritance but, at the moment, a specific gene has 
not been identified.                                                                                                             
Outcome
            Congenital JET is hampered by high mortality, with up to 34% mortality rate. The exact 
mechanism related to death in congenital JET is still unclear. Most are sudden death, that has 
been found also in children with "well compensated" tachycardia2. Sporadic case of sudden 
death has been attributed to a dramatic evolution to paroxysmal complete AV block (2; 10). 
Probably, the dramatic clinical course of these patients is the extreme expression of the 
pathological process occurring in the His bundle region, causing JET in a first time and finally 
the complete loss of AV conduction.  Necropsy reports underlined the importance of His-bundle 
fibbers severe disruption11,12 or focal degeneration and split2. In other cases the arrhythmia has 
been attributed to extensive abnormalities involving the whole atrio-ventricular junction13 or to 
an intra-His bundle tumour originating from Purkinje cells14. Henneveld reported a case of an 8 
months old girl affected by a rapid ventricular rate JET, who developed two years later a 
complete heart block with rapidly increasing left ventricular end diastolic diameter10. The 
patient   was   not   assuming   therapy   at   the   time   of   the   onset   of   complete   heart   block. 
In other cases it can not be excluded that a pharmacological treatment can be responsible of the 
depression of ventricular excitability, leading to a slow unsatisfactory ventricular escape rhythm 
in case of AV block and sudden cardiac death. However, in some cases it can not be excluded 
the potential proarrhythmic effect of the drugs used to control the arrhythmia15. In our series, 
two patients developed symptomatic non-sustained life-threatening ventricular tachycardia as a 
spontaneous desincronization of junctional ectopic tachycardia, due to a proarrhythmic effect of 
the combination of used drugs (Amiodarone + Propafenone and Amiodarone + Flecainide)6. 
Pharmacological Treatment                                                                                   
            Treatment is indicated in infants with symptoms, reduced ventricular function or rapid 
rates  16,17. The management of infants with slow JET (less than 150 beats/min) without 
symptoms appear to be debated. However, necessity to monitor accurately these asymptomatic 
patients is undoubted. It has been reported a case in which an asymptomatic patient at birth with 
junctional ectopic tachycardia with a ventricular rate of 140 beats/min returned at 6 weeks of age 
in cardiovascular collapse due to a ventricular rate of 300 beats/min2. The pharmacological 
treatment of JET is hampered by a high rate of failures. Several drugs have been tested, but a 
comprehensive analysis of efficacy has not been performed yet. The largest study available is a 
multicenter study performed in nineties by European and American teams who reviewed dates of 
26 pts treated with digoxin, propranolol and/or amiodarone  2. The largest single centre 
experience of pharmacological treatment has been recently reported, with the use of Amiodarone, 
Flecainide or Propafenone alone or in combination6. Digoxin did not affect ventricular rate in 
any patients and has been demonstrated to be not completely safe in patients with congenital 
JET. Sporadic cases have been reported in which patients affected by congenital JET and severe 
cardiac failure developed ventricular fibrillation or faster tachycardia (up to 400 beats/min) 
during progressive digoxin loading 2. Amiodarone seems to have the highest response rates: it 
has been shown to be effective alone in decreasing the ventricular rate to less than 150 beats/min 
in a percentage between 50-70% of the cases 2,6. Sporadic reports of medical treatment efficacy 
exist   also   about   Propafenone6,18,   Flecainide   or   Encainide6,19  and   Sotalol20.   However, 
Propafenone has been shown to result particularly effective in preventing or controlling the 
tachycardia only in patients with lower heart rate6.                                         . 
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           Other studies have also tested phenytoin, which was able to control ventricular rate but 
caused ataxia, ajmaline, which intravenous infusion was followed by ventricular tachycardia and 
verapamil which caused cardiovascular collapse2. Personal experience has shown that in those 
cases not responding to a single drug regimen, as association of antiarrhythmic agents with 
different electrophysiological effects (Amiodarone + a Ic antiarrhythmic drug) may control 
otherwise untreatable congenital JET. Otherwise the association Propafenone or Flecainide plus 
Amiodarone   could   reduce   the   Amiodarone   dose   keeping   an   high   efficacy   of   the 
pharmacological therapy6. Recently Dorman et al. have described a protective effect of 
magnesium supplementation on JET in paediatric patients undergoing surgery for congenital 
heart defects21. This could be due to the stabilization of the membrane potential and the 
reduction of the automaticity, resulting in a low rate of development of the arrhythmia. Further 
studies are needed to evaluate the potential role of magnesium in the treatment of the congenital 
form of JET. All pharmacological therapies are burdened by a high risk of toxicity as they have 
to be maintained at high dosage for long time in young patients. Congestive heart failure is a 
frequent complication of JET with high ventricular rate and its management is even more 
difficult. In these cases it has been underlined the negative inotropic effects of antiarrhythmic 
drugs and the limitations in the use of sympathomimetic agents. Isoproterenol, dopamine, 
dobutamine and amrinone all increase the JET rate. Sodium Nitroprusside has to be avoided too, 
since low blood pressure will reflexly increase adrenergic tone.                                                 
Non pharmacological treatment                                                                             
           A definitive treatment could be the removal of the arrhythmogenic area. Surgical His 
ablation has been attempted in some critical patients, with contrasting results2. In one case 
cautery surgical ablation led to the development of ventricular tachycardia. Radiofrequency 
catheter ablation of JET was reported for the first time in the eighties22,23. It required, in the first 
procedures, the elimination of AV conduction tissue with the following pacemaker implantation. 
In nineties radiofrequency catheter ablation technique was able to control the tachycardia with 
the preservation of the normal AV conduction9. Lesions were carried out in the region between 
the coronary sinus and the anterior septum, moving progressively anteriorly to a site where a 
small His deflection was recorded. In some cases His-bundle localization can be uncommon, in 
view of the fact that a His-bundle has been found on the left sided of the interventricular 
septum2. Recent experiences have proven the feasibility of the selective modification of the AV 
junction without the complete destruction of the conduction system even in small children, less 
than one year old24. Very controversial is still the matter of prophylactic pacemaker implant to 
prevent sudden death. In the multicenter study2  most part of patients did not undergo to 
pacemaker implantation, but four patients with well compensated JET died suddenly and in one 
of those a slow ventricular rate was recorded during the terminal event. Walsh suggested to 
evaluate AV conduction with transesophageal electrophysiological test in all patients with 
congenital   JET   and   consider   pacemaker   insertion   only   if   impaired   conduction   can   be 
demonstrated by atrial stimulation, or by the observation of spontaneous AV block on ECG and 
Holter   monitoring25.                                                                                      
Conclusions
            Since JET therapy relay on different medical options, a staged treatment protocol is 
advisable: a pharmacological approach should be tested and carried on, also with a multi drug 
treatment, while catheter ablation can be a definitive option in critically ill patients, when drugs 
fail or when tachycardia becomes chronic and the patient is dependent on a potentially toxic 
therapy.
References
1. Coumel P., Fidelle J.E., Attuel P., Brechenmacher C., Batisse A., Bretagne J., Clementy J., Gerard R., Grolleau 
R., Huault G., Mouy A., Nouvailles J., Kachaner J., Ribierre M., Toumieux M.C.: Tachycardies focales hisiennes 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 3(3): 143-147 (2006)Berardo Sarubbi, Pasquale Vergara, Michele D'Alto, Raffaele Calabro,                                           147 
“Congenital Junctional Ectopic Tachycardia: Presentation And Outcome”
congenitales:   etude   cooperative   de   sept   cas.   Arch.   Mal.   Coeur.   1976;   69:899-903.
2.  Villain E., Vetter V.L., Garcia J.M., Herre J., Cifarelli A., Garson A. Jr.: Evolving concepts in the management 
of   congenital   junctional   ectopic   tachycardia.   A   multicenter   study.   Circulation   1990;   81:1544-1549.      
3.  Brechenmacher C., Coumel P, James TN. Intractable tachicardia in infancy. Circulation 1976; 53:377.
4.  Villazon E, Fouron JC, Fournier A, Proulx F: Prenatal diagnosis of junctional ectopic tachycardia. Pediatr 
Cardiol.   2001   22:160-162.                                                    
5.  Benito Bartolome F, Jimenez Casso S: Hydrops fetalis secondary to junctional ectopic tachycardia. Rev. Esp. 
Cardiol.   2000;53:1529-1530.                                                
6.  Sarubbi B, Musto B, Ducceschi V, D'Onofrio A, Cavallaro C, Vecchione F, Musto C, Calabro R. Congenital 
junctional ectopic tachycardia in children and adolescents: a 20 year experience based study. Heart. 2002; 
88(2):188-90.
7. Garson A, Gillette PC. Junctional ectopic tachycardia in children: electrocardiography, electrophysiology and 
pharmacological   response.   Am   J   Cardiol   1979;44:298:302.                                                          
8.  Rossi AF, Kipel G, Golinko RJ, Griepp RB. Use of adenosine in postoperative junctional ectopic tachycardia 
with 1:1 retrograde atrial conduction. Am Heart J. 1991 Apr;121(4 Pt 1):1237-9.
9.  Scheinman MM, Gonzalez RP, Cooper MW, Lesh MD, Lee RJ, Epstein LM. Clinical and electrophysiologic 
features and role of catheter ablation techniques in adult patients with automatic atrioventricular junctional 
tachycardia. Am J Cardiol 1994;74:565-572
10. Henneveld H, Hutter P, Bink-Boelkens M, Sreeram N. Junctional ectopic tachycardia evolving into complete 
heart block. Heart. 1998 Dec;80(6):627-8.
11. Brechenmacher C., Coumel P., James T.N.: Intractable tachycardia in infancy. Circulation 1976; 53: 377-381. 
12.  Till J.A., Ho S.Y., Rowland E.: Histopathological findings in three children with His bundle tachycardia 
occurring subsequent to cardiac surgery. Eur. Heart J. 1992; 13:709-712 
13.  Bharati S, Moskowitz WB, Scheinman M., Estes N.A., Lev M.: Junctional tachycardias: anatomic substrate 
and its significance in ablative procedures. J. Am. Coll. Cardiol. 1991; 18:179-186. 
14. Rossi L., Piffer R., Turolla E., Frigerio B., Coumel P., James T.N.: Multifocal Purkinje like tumour of the heart: 
occurrence with other anatomic abnormalities in the atrioventricular junction of an infant with junctional 
tachycardia, Lown-Ganong-Levine syndrome and sudden death. Chest 1985; 87:340-343.                         
15. Yap S.C., Hoomtje T., Sreeram N: Polymorphic ventricular tachycardia after use of intravenous amiodarone for 
postoperative   junctional   tachycardia.   Int.   J.   Cardiol.   2000;   76:245-247.                    
16.  Wren C.: Incessant tachycardias: Eur. Heart J. 1998; 19 suppl E: E32-E36.                                               
17. Walsh EP, Saul P, Sholler GF, Triedman JK, Jonas RA, Mayer JE, Wessel DL: Evaluation of a staged treatment 
protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 
1997;   29:1046-1053.                                                                        
18.  Paul T, Reimer A, Janousek J, Kallfelz HC. Efficacy and safety of Propafenone in congenital junctional ectopic 
tachycardia.   J   Am   Coll   Cardiol   1992;20:911-4.                                                        
19. Kuck KH, Kunze KP, Schluter M, Duckeck W. Encainide versus flecainide for chronical atrial and junctional 
ectopic   tachycardia.   Am   J   Cardiol   1988;   62:37L-44L.                                                        
20.  Maragnes P, Fournier A, Davignon A. Usefulness of oral sotalol for the treatment of junctional ectopic 
tachycardia.   International   Journal   of   Cardiology   1992;35:165-167.                                              
21. Dorman BH, Sade RM, Burnette JS, Wiles HB, Pinosky ML, Reeves ST, Bond BR, Spinale FG. Magnesium 
supplementation in the prevention of arrhythmias in pediatric patients undergoing surgery for congenital heart 
defects.   Am   Heart   J.   2000   Mar;139(3):522-8.                                                          
22. Gallagher JJ, Svenson RH, Kasell JH, et al Catheter technique for closet chest ablation of the atrioventricular 
conduction system. A therapeutic alternative for the treatment of supraventricular tachycardia. N Engl J Med 
1982;306:194.
23. Gillette PC, Garson A, Porter CJ, Ott D, McVey P, Zinner A, Blair H. Junctional automatic ectopic tachicardia: 
new proposed treatment by transcatheter His bundle ablation. Am Heart J 1983; 106:619-623.                     
24.  Fishberger SB, Rossi AF, Messina JJ, Saul JP. Successful radiofrequency catheter ablation of congenital 
junctional ectopic tachycardia with preservation of atrioventricular conduction in a 9-month-old infant. Pacing Clin 
Electrophysiol.   1998   Nov;21(11   Pt   1):2132-5.                                              
25. Walsh EP, Saul JP, Triedman JK Cardiac arrhythmias in children and young adults with congenital heart 
disease. Lippincott Williams and Wilkins 2001. 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 3(3): 143-147 (2006)